Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00198016
Status:
COMPLETED
Last Update Posted:
2008-10-17
First Post:
2005-09-12
Brief Title:
Coil Embolization of Coronary Artery Fistulas
Sponsor:
HOSPITEN
Organization:
HOSPITEN
Study Overview
Official Title:
Coil Embolization of Coronary Artery Fistulas A Single Centre Experience
Status:
COMPLETED
Status Verified Date:
2005-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background and Purpose Congenital coronary artery fistula CAF is an uncommon anomaly In some patients they can became symptomatic associated with significant morbidity and mortality We report our experience in percutaneous treatment of CAF
Detailed Description:
Congenital coronary artery fistula CAF can be defined as a direct communication of a coronary artery with a cardiac chamber great vessel or other vascular structure bypassing the myocardial capillary bed
CAF is an uncommon anomaly occurring as an incidental finding in 01 to 02 of coronary angiograms They are not gender specific Many patients have symptoms like congestive heart failure infective endocarditis myocardial ischemia or rupture of an aneurismal fistula Surgical closure of coronary artery fistula was initially reported in 1983 with low rates of morbidity and mortality
Percutaneous treatment appeared as an alternative to surgery Transcatheter closure of CAF was first utilized in 1983 Along this years with experience and improvements in catheterization equipment and occlusion devices CAF occlusion have been successfully performed using microcoils
We report our experience in using microcoils to percutaneous treatment of coronary fistulas
CAF is an uncommon anomaly occurring as an incidental finding in 01 to 02 of coronary angiograms They are not gender specific Many patients have symptoms like congestive heart failure infective endocarditis myocardial ischemia or rupture of an aneurismal fistula Surgical closure of coronary artery fistula was initially reported in 1983 with low rates of morbidity and mortality
Percutaneous treatment appeared as an alternative to surgery Transcatheter closure of CAF was first utilized in 1983 Along this years with experience and improvements in catheterization equipment and occlusion devices CAF occlusion have been successfully performed using microcoils
We report our experience in using microcoils to percutaneous treatment of coronary fistulas
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None